Search Results

Displaying Results 101-125 of 156 "'IE'"

Nov 04, 2025, 10:03 ET Halo ai and Markel Launch the Next Generation of Equine Insurance and Performance Prediction

Download Halo for iPhone here: https://apps.apple.com/ie/app/halo-ai/id6503727756 About Halo Halo

More news about: Halo AI Technologies


Oct 30, 2025, 07:00 ET Hot Chili Quarterly Report Period Ending 30 September, 2025

Note: if the entity has reported positive relevant outgoings(ie a net cash inflow) in item 8.3, answer item 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must

More news about: Hot Chili Limited


Oct 23, 2025, 08:00 ET 2 New Published Studies Highlight SeptiCyte RAPID's Strong Performance and Clinical Utility in Post Cardiac Surgery Patients

included cardiac intensive care patients with infective endocarditis (IE) or undergoing elective cardiac surgery at the Città della Salute e della Scienza University Hospital in Turin, Italy. The data indicated an elevated SeptiScore in IE patients which correlated with greater clinical severity, higher

More news about: Immunexpress, Inc.


Oct 22, 2025, 07:00 ET Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc

trading on the Nasdaq Global Market under the ticker symbol "AVDL." The International Securities Identification Number for these securities is IE00BDGMC594. In addition, as of October 20, 2025 (being the latest practicable date prior to the publication of this Announcement), there

More news about: Alkermes plc; Avadel Pharmaceuticals plc


Oct 16, 2025, 08:00 ET TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care

subsequent infusions. In EQUULEUS, patients receiving combination treatment (n=97) were administered the first 16 mg/kg dose at Week 1 split over two days, ie, 8 mg/kg on Day 1 and Day 2, respectively. The incidence of any grade infusion-related reactions was 42%, with 36% of patients experiencing infusion-related

More news about: Johnson & Johnson


Oct 16, 2025, 07:01 ET The 7iE Smart Matter WiFi Thermostat by Warmup

Matter Compatibility The 7iE Smart Matter WiFi Thermostat is Warmup's most advanced underfloor heating controller ever. Combining premium materials with market-leading automation innovation, the 7iE features Matter technology to ensure effortlessly integration with

More news about: Warmup plc


Oct 15, 2025, 20:58 ET Pasqua Wines Welcomes Andrea Pasqua as Head of Business Development, Marking a New Chapter in the Family's Leadership

earning a degree in Business Economics and Management from Bocconi University in Milan, he completed a Master's in International Management at IE Business School in Madrid, followed by an executive program at the London School of Economics. His first exposure to the industry came through

More news about: Pasqua Wines


Oct 14, 2025, 07:10 ET Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior

TBC Scheffer IE, Nabbout R, Lagae L, et al. Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome. Epilepsia. 2025;66(6):1919-32. Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy

More news about: UCB


Oct 13, 2025, 02:18 ET Lundbeck's bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies

Ren A, et al. J Medicinal Chem. 2025;68(11):10599-10618 Scheffer IE, et al. Epilepsia. 2025;00:1-10 Palmer EE, et al. Neurotherapeutics. 2021;18(3):1432–1444 Gallop

More news about: H. Lundbeck A/S


Oct 10, 2025, 18:24 ET Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors

(NYSE: IFF), where he is on the innovation and audit committees. He is a Senior Advisor for NASDAQ, the Council for Global Competition and Innovation and IE University New York College and is vice chair of the board of HITEC. Mantas recently retired as the global leader of IBM Business Transformation Services.

More news about: National Association of Corporate Directors


Oct 08, 2025, 17:55 ET High Recovery Caesium Concentrate Produced from Latest Metallurgical Testwork at Shaakichiuwaanaan

Nature of quality control procedures adopted (eg standards, blanks, duplicates, external laboratory checks) and whether acceptable levels of accuracy (ie lack of bias) and precision have been established.  

More news about: PMET Resources Inc.


Sep 29, 2025, 10:16 ET Edwardson School of Industrial Engineering at Purdue University and VMS Solutions Forge Strategic Partnership to Address Semiconductor Talent Shortage

the complex dynamics of semiconductor production environments. Edwardson School of Industrial Engineering at Purdue will start to use this software in IE 490: Semiconductor Manufacturing and Supply Chain in the fall semester, with plans to expand its use into more courses. Students will engage with real-world

More news about: VMS Solutions


Sep 25, 2025, 06:30 ET VIAVI Expands ONE LabPro® ONE-1600 1.6Tb Testing and Validation Platform

ONE LabPro® testing and validation platform. Following the launches of the ONE-1600 and second generation ONE-1600IE solutions, the new ONE-1600ER module delivers enhanced features and enables comprehensive testing on a single platform for next-generation 1.6Tb optical

More news about: VIAVI Solutions


Sep 24, 2025, 17:00 ET Marketable Tantalite Concentrates Successfully Produced from the CV5 Deposit at Shaakichiuwaanaan

Nature of quality control procedures adopted (eg standards, blanks, duplicates, external laboratory checks) and whether acceptable levels of accuracy (ie lack of bias) and precision have been established. 

More news about: PMET Resources Inc.


Sep 19, 2025, 08:30 ET TECVAYLI® and DARZALEX FASPRO®-based induction treatment demonstrates promising rates and depths of response in transplant-eligible patients with newly diagnosed multiple myeloma

subsequent infusions. In EQUULEUS, patients receiving combination treatment (n=97) were administered the first 16 mg/kg dose at Week 1 split over two days, ie, 8 mg/kg on Day 1 and Day 2, respectively. The incidence of any grade infusion-related reactions was 42%, with 36% of patients experiencing infusion-related

More news about: Johnson & Johnson


Sep 18, 2025, 05:00 ET CKGSB and IE University launch data-driven report on China's economic influence in Africa

/PRNewswire/ -- Cheung Kong Graduate School of Business, the IE China Observatory, and the IE Africa Program have launched a new report –

More news about: Cheung Kong Graduate School of Business (CKGSB)


Sep 18, 2025, 05:00 ET CKGSB and IE University launch data-driven report on China's economic influence in Africa

/PRNewswire/ -- Cheung Kong Graduate School of Business, the IE China Observatory, and the IE Africa Program have launched a new report –

More news about: Cheung Kong Graduate School of Business (CKGSB)


Sep 17, 2025, 23:39 ET Inland Empire Health Plan statement on Department of Justice filing

DualChoice (those with both Medi-Cal and Medicare). As of 2024, IEHP also offers Covered California plans, further ensuring health care access for even more IE residents. Today, IEHP has a robust network of quality doctors throughout our two counties and nearly 4,000 team members who are fully committed to the

More news about: Inland Empire Health Plan (IEHP)


Sep 15, 2025, 14:00 ET Inland Empire Health Plan listed as a Fortune Best Workplaces in Health Care™ for fourth year

DualChoice (those with both Medi-Cal and Medicare). As of 2024, IEHP also offers Covered California plans, further ensuring health care access for even more IE residents. Today, IEHP has a robust network of quality doctors throughout our two counties and nearly 4,000 team members who are fully committed to the

More news about: Inland Empire Health Plan (IEHP)


Sep 11, 2025, 10:21 ET Imaging Endpoints kündigt Patentanmeldung für AI Review Charter System an

Endpoints Imaging Endpoints (IE) konzentriert sich mit großer Leidenschaft auf seine Vision, die Bildgebung mit der Heilung zu verbinden. Mit einer makellosen globalen Inspektionsbilanz und einer bemerkenswerten Erfolgsquote von 95 % bei der Marktzulassung verfügt IE über eine nachweisliche Erfolgsbilanz

More news about: Imaging Endpoints


Sep 11, 2025, 10:15 ET Imaging Endpoints annonce le dépôt d'une demande de brevet pour un son système Imaging Review Charter optimisé par l'IA

Endpoints Imaging Endpoints (IE) se concentre avec passion sur sa vision de connecter l'imagerie à la guérison. Avec un dossier d'inspection mondial irréprochable et un taux de réussite remarquable de 95 % en matière d'autorisation de mise sur le marché, IE a prouvé sa capacité à soutenir des

More news about: Imaging Endpoints


Sep 11, 2025, 02:49 ET Imaging Endpoints anuncia la solicitud de patente para su sistema de revisión de imágenes mediante IA

Endpoints Imaging Endpoints (IE) está firmemente comprometida con su visión de conectar la imagen con la cura. Con un impecable historial de inspecciones a nivel mundial y una tasa de éxito del 95% en la obtención de autorizaciones de comercialización, IE cuenta con una trayectoria probada en

More news about: Imaging Endpoints


Sep 10, 2025, 09:00 ET Imaging Endpoints Announces Patent Application for AI Review Charter System

Trials About Imaging Endpoints Imaging Endpoints (IE) is passionately focused on its vision to Connect Imaging to the Cure. With a flawless global inspection record and a remarkable 95% marketing authorization success rate, IE has a proven track record of supporting successful regulatory

More news about: Imaging Endpoints


Sep 10, 2025, 09:00 ET Imaging Endpoints Announces Patent Application for AI Review Charter System

Trials About Imaging Endpoints Imaging Endpoints (IE) is passionately focused on its vision to Connect Imaging to the Cure. With a flawless global inspection record and a remarkable 95% marketing authorization success rate, IE has a proven track record of supporting successful regulatory

More news about: Imaging Endpoints


Sep 09, 2025, 12:35 ET AVATR VISION XPECTRA hace su debut mundial y AVATR presenta su diseño original en Múnich

Technology celebró su "Día de la Marca AVATR: Un Nuevo Horizonte Brillante" en UTOPIA München, Múnich, Alemania. El primer vehículo de visión inteligente (IE) del mundo, el AVATR VISION XPECTRA, debutó junto con el AVATR 012 de edición limitada, cocreado con Kim Jones, el exclusivo

More news about: Avatr Technology (Chongqing) Co., Ltd


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.